Most companies used Chinese Valsartan ingredients were small and medium-sized
As it was indicated that the active pharmaceutical ingredient ‘Valsartan’ manufactured by Zhejiang Huahai will likely to be used, sales suspension of 91 out of 219 antihypertensive products has been cleared off. The rest of 128 products were small and medium pharmaceutical companies’ products.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.